<- Go Home
Ovid Technologies, Inc.
Ovid Technologies, Inc. operates medical research platforms for customers worldwide. It offers access to journals, books, ebooks, and databases in the areas of cardiology, critical care medicine, dentistry, food science and nutritions, gastroenterology and hepatology, health profession, neurology, nursing, OBGYN, oncology, orthopedics and sports medicines, pain management and anesthesia, pulmonary medicine, public health, radiology, surgery, transplantation, and veterinary and animal sciences. Its platforms include Ovid to access and work with online journals, books, and databases; OvidToday to browse through journals, keep track of favorites, and read relevant content; OvidMD, a clinical tool that provides answers to clinical questions based on relevant full—text content; Nursing@Ovid, a nursing and allied health portal for practice, education, research, and administration; solutions to browse, search, and manage results of Chinese, Spanish, French language medical and research content; JBI Resources on Ovid, which provides content and tools that allow institutions to implement evidence–based practice; and PayPerView service, which enables clinicians, students, and researchers to expand their information reach by purchasing immediate access to the text content in Journals@Ovid to which their institution has not subscribed. Its platform helps researchers, librarians, clinicians, and other healthcare professionals to find medical information and make critical decisions to improve patient care, enhance ongoing research, and fuel new discoveries. Ovid Technologies, Inc. was formerly known as CD Plus, Inc. and changed its name to Ovid Technologies, Inc. in 1995. The company was founded in 1988 and is based in New York, New York. Ovid Technologies, Inc. operates as a subsidiary of Wolters Kluwer N.V.
Market Cap
$154.6M
Volume
23.8K
Cash and Equivalents
$2.6M
EBITDA
-$6.9M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$11.6M
Profit Margin
42.04%
52 Week High
$26.63
52 Week Low
$8.88
Dividend
N/A
Price / Book Value
15.81
Price / Earnings
-22.04
Price / Tangible Book Value
15.81
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$9.3M
Return on Equity
53.30%
Return on Assets
-17.08
Cash and Short Term Investments
$11.3M
Debt
$1.3M
Equity
$9.4M
Revenue
$27.7M
Unlevered FCF
-$106.1K
Sector
Health Care Technology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium